4.4 Review

Gastrointestinal absorption of uranium compounds - A review

期刊

REGULATORY TOXICOLOGY AND PHARMACOLOGY
卷 71, 期 1, 页码 125-133

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.yrtph.2014.08.012

关键词

Uranium; Absorption; Species differences; Toxicity

向作者/读者索取更多资源

Uranium occurs naturally in soil and rocks, and therefore where it is present in water-soluble form it also occurs naturally in groundwater as well as in drinking water obtained from groundwater. Animal studies suggest that the toxicity of uranium is mainly due to its damage to kidney tubular cells following exposure to soluble uranium compounds. The assessments of the absorption of uranium via the gastrointestinal tract vary, and this has consequences for regulation, in particular the derivation of e.g. drinking water limit values. Absorption rates vary according to the nature and solubility of the compound in which uranium is presented to the test animals and depending on the animal species used in the test. No differences for sex have been observed for absorption in either animals or humans. However, human biomonitoring data do show that boys excrete significantly more uranium than girls. In animal studies neonates took up more uranium than adults or older children. Nutritional status, and in particular the iron content of the diet, have a marked influence on absorption, and higher uranium levels in food intake also appear to increase the absorption rate. If the pointers to an absorption mechanism competing with iron are correct, these mechanisms could also explain the relatively high concentration and chemical toxicity of uranium in the kidneys. It is here (and in the duodenum) that divalent metal transporter 1 (DMT1), which is primarily responsible for the passage of iron (or uranium?) through the cell membranes, is most strongly expressed. (C) 2014 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
Article Medicine, Legal

New supporting data to guide the use of evident toxicity in acute oral toxicity studies (OECD TG 420)

Fiona Sewell, Ian Ragan, Graham Horgan, David Andrew, Thomas Holmes, Irene Manou, Boris P. Mueller, Tim Rowan, Barbara G. Schmitt, Marco Corvaro

Summary: There are currently three test guidelines for acute oral toxicity studies, but the subjectivity of one guideline may be hindering its wider use. In order to address this, the NC3Rs and EPAA collaborated to analyze historical data and provide recommendations on the recognition of 'evident toxicity'.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2024)

Article Medicine, Legal

The 2022 world health organization reevaluation of human and mammalian toxic equivalency factors for polychlorinated dioxins, dibenzofurans and biphenyls

Michael DeVito, Bas Bokkers, Majorie B. M. van Duursen, Karin van Ede, Mark Feeley, Elsa Antunes Fernandes Gaspar, Laurie Haws, Sean Kennedy, Richard E. Peterson, Ron Hoogenboom, Keiko Nohara, Kim Petersen, Cynthia Rider, Martin Rose, Stephen Safe, Dieter Schrenk, Matthew W. Wheeler, Daniele S. Wikoff, Bin Zhao, Martin van den Berg

Summary: In October 2022, the World Health Organization reevaluated the toxic equivalency factors (TEFs) for chlorinated dioxin-like compounds in a panel convened in Lisbon. This effort utilized an updated database, Bayesian dose response modeling, and meta-analysis to derive Best-Estimate TEFs. Applying these new TEFs may result in lower total toxic equivalents for dioxin-like chemicals.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2024)